with tumoroids
in the clinostar

What is a cancerous tumoroid?

As cancer cells accumulate changes in their genetic makeup (mutations) and how genes are regulated (epigenetic alterations, red), they gradually relinquish the intricate controls that usually manage their behavior. This loss of control sets the stage for cells to multiply uncontrollably and adopt invasive characteristics, ultimately coalescing into tumoroids. These tumoroids are a significant menace to the body’s overall balance.

In the evolving landscape of oncology, the concept of “cancerous tumoroids” is gaining recognition, denoting irregular growths distinguished by their unregulated cell division and tendency to invade surrounding tissues. These growths prominently display the key indicators of malignancy, showcasing the capability to spread to distant sites through metastasis, thereby perturbing the usual arrangement of healthy tissues.

Blastocyst graphic.

White Paper

Start your journey of designing relevant in vitro models for optimal cancer research.

Read about cell culture techniques and how to validate cell culture models.
White Paper

How Christophe Deben cultivates tumoroids in the ClinoStar

See how Christophe Deben from the Center of Oncological Research at Antwerpen University uses the ClinoStar to cultivate organoids. Get insights into how Christophe and his team aim to introduce patient-derived organoids in preclinical and clinical developments.

Please accept statistics, marketing cookies to watch this video.

Blog post: A critical look at patient-derived organoids and immortal cell lines

Between the frying pan and the fire – is it time to jump? Cell lines are inexpensive, easy to handle and reproducible. For that reason they have been widely used for understanding the molecular basis of cancer and for drug screening. But maybe, now is the time to transfer to Patient-derived organoids?

How to work with cancer cells in 3D cell culture

Two methods are commonly employed when creating cancer spheroids: Scaffold-Based Systems and Spheroids.

  • Scaffold-Based Systems: This technique utilizes scaffold materials like hydrogels, porous polymers, or natural extracellular matrix components (such as collagen or Matrigel). These scaffolds serve as supportive frameworks. Initially, cancer cells are combined with the scaffold material and then placed within a suitable culture vessel. The scaffold is a platform for cells to anchor onto and grow three-dimensional. Over time, cells proliferate into a 3D structure resembling the growth pattern of tumors in the body.
  • Scaffold-Free Systems: Organoids or spheroids are formed when cancer cells naturally aggregate into spherical clusters. This is achieved by culturing cells in suspension, meaning they are not attached to a surface.

Both approaches offer insights into cancer cell behavior in a more realistic 3D environment, enhancing our understanding of their growth and response to treatment. Scaffold-based systems provide a structured foundation for cell growth, while Scaffold-free systems involve cells uniting naturally in a suspended environment, akin to forming clusters resembling small tumors. These methods, including the innovative use of rotary bioreactors, contribute to our knowledge of cancer biology and therapeutic strategies.

How to work with cancer organoids in the ClinoStar

Utilizing the Clinostar for cancer tumoroid production enhances consistency, gas, and nutrient exchange in simulated microgravity conditions. This, in turn, allows for very long-term cultures (up to a year or more), providing a more accurate and informative platform for studying cancer cell behavior. The unique advantages of the Clinostar contribute not only to terrestrial cancer research but also offer insights into how cancer cells might respond in space-related contexts.

Using a rotary bioreactor, like the ClinoStar, gives scientists distinct advantages when producing cancer tumoroids. An example is that the controlled rotation of the ClinoStar promotes uniform cell aggregation, resulting in consistent tumoroid size and structure. The long-term culture allows the growth rate of the cancer cells to fall to that seen in cancers in vivo. These features ensure that experimental results are reliable, reproducible, and relevant.


Application Note: Finding novel treatments for triple-negative breast cancer with 3D cell culture

In this blog post, we’ll dive into what triple breast cancer is, and how 3D cell culture can play a crucial role in finding novel treatments as illustrated in our newest application note. 


Keep in touch

Make sure you never miss a message.

Sign up for CelVivo’s monthly newsletter and get all the latest ClinoStar research, 3D cell culture trends, insightful symposiums, and exclusive webinars.

ClinoStar Research

Get inspired by the newest research made with the ClinoStar system.

A Novel NCI-H69AR Drug-Resistant Small-Cell Lung Cancer Mini-Tumor Model for Anti-Cancer Treatment Screening

DOI: 10.3390/cells12151980

Small-cell lung cancer is a fast-growing carcinoma with a poor prognosis and a high level of relapse due to multi-drug resistance (MDR).

Investigation of reversible histone acetylation and dynamics in gene expression regulation using 3D liver spheroid model

DOI: 10.1186/s13072-022-00470-7

A demonstration, that 3D liver spheroids are a suitable system to model chromatin dynamics and response to epigenetics inhibitors.


A novel NCI-H69V small cell lung cancer functional mini-tumor model for future treatment screening applications

DOI: 10.1002/btpr.3253

In vitro cancer models are crucial in chemotherapy development, and three-dimensional (3D) models aim to bridge the gap between two-dimensional (2D) flat cultures and in vivo testing.

Start optimising your 
In Vitro models today